Delta-like ligand 3 (DLL3) is normally expressed at low levels in normal tissue but exhibits very high expression in tumors of neuroendocrine origin with more than 80% of SCLC samples showing high expression [54, 55]. This evidence concerns the gene DLL3 and small cell lung carcinoma.